Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling
暂无分享,去创建一个
[1] M Segal,et al. Geometry of dendritic spines affects calcium dynamics in hippocampal neurons: theory and experiments. , 1999, Journal of neurophysiology.
[2] D. Kang,et al. Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels* , 2012, The Journal of Biological Chemistry.
[3] M. Rahgozar,et al. Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population , 2010, Avicenna journal of medical biotechnology.
[4] W. Lederer,et al. Models of Ca2+ release channel adaptation. , 1995, Science.
[5] Grace E Stutzmann,et al. Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability , 2004, The Journal of Neuroscience.
[6] J. Rinzel,et al. Equations for InsP3 receptor-mediated [Ca2+]i oscillations derived from a detailed kinetic model: a Hodgkin-Huxley like formalism. , 1994, Journal of theoretical biology.
[7] S. Feske,et al. Reduced Synaptic STIM2 Expression and Impaired Store-Operated Calcium Entry Cause Destabilization of Mature Spines in Mutant Presenilin Mice , 2014, Neuron.
[8] E. Posse de Chaves,et al. Aβ Internalization by Neurons and Glia , 2011, International journal of Alzheimer's disease.
[9] M. Berridge,et al. Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature reviews. Molecular cell biology.
[10] R. J. Kelleher,et al. The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.
[11] M. Mattson,et al. Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.
[12] Alexei Verkhratsky,et al. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. , 2005, Physiological reviews.
[13] J. Fastbom,et al. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies , 1999, Neuroscience.
[14] B. Winblad,et al. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology , 1998, Brain Research.
[15] B. de Strooper,et al. Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore* , 2011, The Journal of Biological Chemistry.
[16] Carson C. Chow,et al. Calcium time course as a signal for spike-timing-dependent plasticity. , 2005, Journal of neurophysiology.
[17] Paul D Allen,et al. Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes. , 2004, The Journal of biological chemistry.
[18] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[19] R. Sadoul,et al. Emerging Role of Neuronal Exosomes in the Central Nervous System , 2012, Front. Physio..
[20] J. Foskett,et al. Regulation by Ca2+ and Inositol 1,4,5-Trisphosphate (Insp3) of Single Recombinant Type 3 Insp3 Receptor Channels , 2001, The Journal of general physiology.
[21] F. Pasquier,et al. A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.
[22] M. Mattson,et al. Presenilin-1 Mutation Increases Neuronal Vulnerability to Focal Ischemia In Vivo and to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis , 2000, The Journal of Neuroscience.
[23] J. Bradley,et al. Up‐regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer’s disease , 2010, Journal of neurochemistry.
[24] F. LaFerla,et al. Enhanced Ryanodine‐Mediated Calcium Release in Mutant PS1‐Expressing Alzheimer's Mouse Models , 2007, Annals of the New York Academy of Sciences.
[25] Don-On Daniel Mak,et al. Inositol trisphosphate receptor Ca2+ release channels. , 2007, Physiological reviews.
[26] W. Levy,et al. Insights into associative long-term potentiation from computational models of NMDA receptor-mediated calcium influx and intracellular calcium concentration changes. , 1990, Journal of neurophysiology.
[27] P. Verkade,et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] I. Bezprozvanny,et al. Theoretical analysis of calcium wave propagation based on inositol (1,4,5)-trisphosphate (InsP3) receptor functional properties. , 1994, Cell calcium.
[29] F. LaFerla,et al. A dynamic relationship between intracellular and extracellular pools of Abeta. , 2006, The American journal of pathology.
[30] T. Pozzan,et al. Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake , 2009, Journal of cellular and molecular medicine.
[31] David B. Sattelle,et al. The effects of amyloid peptides on A-type K+ currents of Drosophila larval cholinergic neurons: modeled actions on firing properties , 2006, Invertebrate Neuroscience.
[32] Samuel Bandara,et al. Regulators of Calcium Homeostasis Identified by Inference of Kinetic Model Parameters from Live Single Cells Perturbed by siRNA , 2013, Science Signaling.
[33] M. Behrens,et al. Redox regulation of RyR-mediated Ca2+ release in muscle and neurons. , 2004, Biological research.
[34] C. Cotman,et al. Alzheimer's Presenilin‐1 Mutation Potentiates Inositol 1,4,5‐Trisphosphate‐Mediated Calcium Signaling in Xenopus , 1999, Journal of neurochemistry.
[35] Zaven S. Khachaturian,et al. Hypothesis on the Regulation of Cytosol Calcium Concentration and the Aging Brain , 1987, Neurobiology of Aging.
[36] T. Iwatsubo,et al. Gain-of-Function Enhancement of IP3 Receptor Modal Gating by Familial Alzheimer’s Disease–Linked Presenilin Mutants in Human Cells and Mouse Neurons , 2010, Science Signaling.
[37] I. Bezprozvanny. The inositol 1,4,5-trisphosphate receptors. , 2005, Cell calcium.
[38] M. Bootman,et al. Alzheimer's disease-associated peptide Aβ42 mobilizes ER Ca2+ via InsP3R-dependent and -independent mechanisms , 2013, Front. Mol. Neurosci..
[39] Ivan V. Goussakov,et al. NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice , 2010, The Journal of Neuroscience.
[40] M. Madesh,et al. STIM proteins: dynamic calcium signal transducers , 2012, Nature Reviews Molecular Cell Biology.
[41] D. Rujescu,et al. CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s Disease , 2011, Molecular medicine.
[42] E. Schon,et al. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease , 2012, The EMBO journal.
[43] S. Duckles,et al. Calcium Regulation in Neuronal Function with Advancing Age: Limits of Homeostasis , 2012 .
[44] C. Hidalgo,et al. Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation , 2011, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. García-Sancho,et al. Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress. , 2011, The Biochemical journal.
[46] F. LaFerla,et al. Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice , 2008, Journal of neurochemistry.
[47] C. Oliveira,et al. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity , 2006, Neurobiology of Disease.
[48] W. Xu,et al. CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population. , 2010, Journal of Alzheimer's disease : JAD.
[49] P. Dodd,et al. Synaptic Degeneration in Alzheimer's Disease , 2011 .
[50] Hyoung-Gon Lee,et al. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide , 2009, Brain Research.
[51] W. Klein,et al. Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.
[52] Martin Falcke,et al. Clustering of IP3 receptors by IP3 retunes their regulation by IP3 and Ca2+ , 2009, Nature.
[53] A. Goate,et al. Presenilin function and γ‐secretase activity , 2005, Journal of Neurochemistry.
[54] Paolo Zamboni,et al. Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.
[55] K. Hensley,et al. Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.
[56] E. Schon,et al. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. , 2009, The American journal of pathology.
[57] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[58] P. Bosco,et al. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. , 2010, Journal of Alzheimer's disease : JAD.
[59] Rui Alves,et al. Tools for kinetic modeling of biochemical networks , 2006, Nature Biotechnology.
[60] J. Shine,et al. Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium* , 2006, Journal of Biological Chemistry.
[61] T. Ozaki,et al. Quantifying the uncertainty of spontaneous Ca2+ oscillations in astrocytes: particulars of Alzheimer's disease. , 2011, Biophysical journal.
[62] J. Sneyd,et al. Models of the inositol trisphosphate receptor. , 2005, Progress in biophysics and molecular biology.
[63] J. Kuźnicki,et al. Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease. , 2009, Biochimica et biophysica acta.
[64] Junichiro Yoshimoto,et al. A model-based prediction of the calcium responses in the striatal synaptic spines depending on the timing of cortical and dopaminergic inputs and post-synaptic spikes , 2013, Front. Comput. Neurosci..
[65] Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[66] P. Greengard,et al. Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .
[67] G. Augustine. How does calcium trigger neurotransmitter release? , 2001, Current Opinion in Neurobiology.
[68] D. Selkoe,et al. Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. , 1997, Journal of neurochemistry.
[69] P. Allen,et al. Calcium Dyshomeostasis in β-Amyloid and Tau-bearing Skeletal Myotubes* , 2004, Journal of Biological Chemistry.
[70] S. DeKosky,et al. No association between CALHM1 variation and risk of Alzheimer disease , 2009, Human mutation.
[71] L. Missiaen,et al. Molecular physiology of the SERCA and SPCA pumps. , 2002, Cell calcium.
[72] J. Keizer,et al. Ryanodine receptor adaptation and Ca2+(-)induced Ca2+ release-dependent Ca2+ oscillations. , 1996, Biophysical journal.
[73] Steven Sheng-Shih Wang,et al. A Kinetic Analysis of the Mechanism of β-Amyloid Induced G Protein Activation , 2003 .
[74] D Holcman,et al. Calcium dynamics in dendritic spines and spine motility. , 2004, Biophysical journal.
[75] E. Schon,et al. Mitochondria-associated ER membranes in Alzheimer disease , 2013, Molecular and Cellular Neuroscience.
[76] P. Greengard,et al. Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.
[77] J. García-Sancho,et al. The sarco/endoplasmic reticulum Ca(2+) ATPase (SERCA) is the third element in capacitative calcium entry. , 2010, Cell calcium.
[78] D. Selkoe,et al. Calcium ionophore increases amyloid beta peptide production by cultured cells. , 1994, Biochemistry.
[79] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[80] Tricia A. Thornton-Wells,et al. Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography , 2013, Human Genetics.
[81] Olivier Thibault,et al. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store , 2007, Aging cell.
[82] Ian Parker,et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. , 2008, The Journal of general physiology.
[83] M. Mattson,et al. Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.
[84] Y. Christen,et al. Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.
[85] C. Oliveira,et al. Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5‐triphosphate receptors in the neurotoxic effects induced by the amyloid‐β peptide , 2004, Journal of neuroscience research.
[86] Mark P Mattson,et al. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders , 2000, Trends in Neurosciences.
[87] O. Maes,et al. MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders , 2009, Current genomics.
[88] Natasha P Wilson,et al. Modeling the short time-scale dynamics of β-amyloid-neuron interactions. , 2013, Journal of theoretical biology.
[89] E. Lea,et al. Kinetic model of the inositol trisphosphate receptor that shows both steady-state and quantal patterns of Ca2+ release from intracellular stores. , 2003, The Biochemical journal.
[90] A. Ruiz,et al. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. , 2010, Journal of Alzheimer's disease : JAD.
[91] C. Ghelardini,et al. A gene‐specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant‐like effect in mice , 2008, Journal of neurochemistry.
[92] Daniel L. Rubin,et al. Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease , 2008, PLoS Comput. Biol..
[93] W. Thies,et al. 2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.
[94] Shaomin Li,et al. Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.
[95] J. Molgó,et al. Early Presynaptic and Postsynaptic Calcium Signaling Abnormalities Mask Underlying Synaptic Depression in Presymptomatic Alzheimer's Disease Mice , 2012, The Journal of Neuroscience.
[96] R. Sitsapesan,et al. Markovian models of low and high activity levels of cardiac ryanodine receptors. , 2001, Biophysical journal.
[97] A. Vortmeyer,et al. Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein , 2013, Neuron.
[98] J. Sneyd,et al. Calcium wave propagation by calcium-induced calcium release: an unusual excitable system. , 1993, Bulletin of mathematical biology.
[99] D. Selkoe,et al. Caffeine Stimulates Amyloid β‐Peptide Release from β‐Amyloid Precursor Protein‐Transfected HEK293 Cells , 1997 .
[100] J. Kotaleski,et al. Modeling The Dynamics of Second Messenger Pathways , 2003 .
[101] E. Kandel,et al. Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.
[102] Michael J. Berridge,et al. Calcium hypothesis of Alzheimer’s disease , 2010, Pflügers Archiv - European Journal of Physiology.
[103] Yigong Shi,et al. Structure of a presenilin family intramembrane aspartate protease , 2012, Nature.
[104] Vivien Kirk,et al. A bifurcation analysis of calcium buffering. , 2006, Journal of theoretical biology.
[105] S. Schuster,et al. Modelling of simple and complex calcium oscillations , 2002 .
[106] Klaus-Peter Lesch,et al. Epigenetically regulated microRNAs in Alzheimer's disease , 2014, Neurobiology of Aging.
[107] K. Oka,et al. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[108] V. Lee,et al. Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.
[109] F. Diederichs. Ion homeostasis and the functional roles of SERCA reactions in stimulus-secretion coupling of the pancreatic beta-cell: A mathematical simulation. , 2008, Biophysical chemistry.
[110] S. Schuster,et al. Modelling of simple and complex calcium oscillations. From single-cell responses to intercellular signalling. , 2002, European journal of biochemistry.
[111] J L van Hemmen,et al. Intracellular Ca2+ stores can account for the time course of LTP induction: a model of Ca2+ dynamics in dendritic spines. , 1995, Journal of neurophysiology.
[112] T. Good,et al. Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[113] J. Schapansky,et al. NF-κB activated by ER calcium release inhibits Aβ-mediated expression of CHOP protein: Enhancement by AD-linked mutant presenilin 1 , 2007, Experimental Neurology.
[114] G. Voeltz,et al. Endoplasmic reticulum–mitochondria contacts: function of the junction , 2012, Nature Reviews Molecular Cell Biology.
[115] F. Benfenati,et al. Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease , 2012, The Journal of Neuroscience.
[116] A Goldbeter,et al. Minimal model for signal-induced Ca2+ oscillations and for their frequency encoding through protein phosphorylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[117] F. LaFerla,et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production , 2008, The Journal of cell biology.
[118] M. Berridge. Calcium regulation of neural rhythms, memory and Alzheimer's disease , 2014, The Journal of physiology.
[119] R. Cowburn,et al. β-amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(1,4,5)trisphosphate and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes , 1995, Neuroscience Letters.
[120] Adriana B Ferreira,et al. β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons* , 2006, Journal of Biological Chemistry.
[121] Yi Zhao,et al. CALHM1 variant is not associated with Alzheimer's disease among Asians , 2011, Neurobiology of Aging.
[122] J. Richardson,et al. Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease , 2012, PloS one.
[123] L. Loew,et al. An image-based model of calcium waves in differentiated neuroblastoma cells. , 2000, Biophysical journal.
[124] M. Mattson,et al. Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.
[125] H. Kretzschmar,et al. Capacitive Calcium Entry Is Directly Attenuated by Mutant Presenilin-1, Independent of the Expression of the Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.
[126] S. Sensi,et al. New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc , 2011, Cell Death and Disease.
[127] S. Rombouts,et al. Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity , 2010, PloS one.
[128] S. Wagner,et al. Ca2+ Influx through Store-operated Ca2+ Channels Reduces Alzheimer Disease β-Amyloid Peptide Secretion* , 2013, The Journal of Biological Chemistry.
[129] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[130] L. Mucke,et al. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.
[131] James Sneyd,et al. A buffering SERCA pump in models of calcium dynamics. , 2006, Biophysical journal.
[132] M. Schuldiner,et al. Staying in touch: the molecular era of organelle contact sites. , 2011, Trends in biochemical sciences.
[133] B. de Strooper,et al. Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. , 2012, Cold Spring Harbor perspectives in medicine.
[134] I. Bezprozvanny,et al. Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. , 2011, Cell calcium.
[135] I. Bezprozvanny,et al. The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.
[136] J. Kuźnicki,et al. Calcium dysregulation in Alzheimer's disease , 2008, Neurochemistry International.
[137] C. Ward,et al. Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle , 2010, Neurobiology of Aging.
[138] Y. Auberson,et al. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. , 2012, Cell Calcium.
[139] R. J. McDonald,et al. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease , 2011, Neuroscience & Biobehavioral Reviews.
[140] J. Foskett,et al. Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling. , 2011, Antioxidants & redox signaling.
[141] Z. Khachaturian,et al. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.
[142] J. Sneyd,et al. Agonist-dependent Phosphorylation of the Inositol 1,4,5-Trisphosphate Receptor , 1999, The Journal of general physiology.
[143] Z. Khachaturian. Calcium Hypothesis of Alzheimer's Disease and Brain Aging a , 1994, Annals of the New York Academy of Sciences.
[144] M. Berridge. Elementary and global aspects of calcium signalling. , 1997, The Journal of physiology.
[145] I. Grundke‐Iqbal,et al. Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.
[146] Satoshi Matsuoka,et al. Role of individual ionic current systems in ventricular cells hypothesized by a model study. , 2003, The Japanese journal of physiology.
[147] Miles W. Miller,et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.
[148] T. Pozzan,et al. Intracellular Calcium Oscillations in Astrocytes: A Highly Plastic, Bidirectional Form of Communication between Neurons and Astrocytes In Situ , 1997, The Journal of Neuroscience.
[149] L. Goldstein,et al. Alzheimer's disease in a dish: promises and challenges of human stem cell models. , 2012, Human molecular genetics.
[150] Thomas M. Morse,et al. Abnormal Excitability of Oblique Dendrites Implicated in Early Alzheimer's: A Computational Study , 2009, Frontiers in neural circuits.
[151] M. Kawahara,et al. Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein , 2011, International journal of Alzheimer's disease.
[152] B. Strooper,et al. Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.
[153] Frank M LaFerla,et al. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. , 2005, Cell calcium.
[154] G. Bett,et al. Computer model of action potential of mouse ventricular myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.
[155] B. Winblad,et al. Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models , 2013, Proceedings of the National Academy of Sciences.
[156] K. T. Blackwell,et al. Approaches and tools for modeling signaling pathways and calcium dynamics in neurons , 2013, Journal of Neuroscience Methods.
[157] I. Parker,et al. Cytotoxicity of Intracellular Aβ42 Amyloid Oligomers Involves Ca2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate , 2013, The Journal of Neuroscience.
[158] G. Binetti,et al. Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease , 2011, Neurobiology of Aging.
[159] S. Hébert,et al. Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. , 2006, Cell calcium.
[160] Jie Shen,et al. Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons , 2013, Proceedings of the National Academy of Sciences.
[161] M. Mattson,et al. Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease , 2011, Pharmacological Reviews.
[162] F. LaFerla,et al. Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2006.050593 Molecular Pathogenesis of Genetic and Inherited Diseases A Dynamic Relationship between Intracellular and Extracellular Pools of A� , 2022 .
[163] J. Keizer,et al. A single-pool inositol 1,4,5-trisphosphate-receptor-based model for agonist-stimulated oscillations in Ca2+ concentration. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[164] Ian Parker,et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.
[165] T. Pozzan,et al. Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia , 2005, Neurobiology of Disease.
[166] Nicholas T. Carnevale,et al. Simulation of networks of spiking neurons: A review of tools and strategies , 2006, Journal of Computational Neuroscience.
[167] J. Watras,et al. Inositol 1,4,5-Trisphosphate (InsP3) and Calcium Interact to Increase the Dynamic Range of InsP3 Receptor-dependent Calcium Signaling , 1997, The Journal of general physiology.
[168] M. Kawato,et al. Inositol 1,4,5-Trisphosphate-Dependent Ca2+ Threshold Dynamics Detect Spike Timing in Cerebellar Purkinje Cells , 2005, The Journal of Neuroscience.
[169] Ata Akin,et al. Modelling of calcium dynamics in brain energy metabolism and Alzheimer's disease , 2005, Comput. Biol. Chem..
[170] S. Pimplikar,et al. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain , 2005, The Journal of cell biology.
[171] D. Bennett,et al. Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease , 2012, Neurobiology of Aging.
[172] P. Smolen,et al. Calcium dynamics in large neuronal models , 1998 .
[173] Brian J. Bacskai,et al. Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.
[174] D. Alkon,et al. Internal Ca 2 + mobilization is altered in fibroblasts from patients with Alzheimer disease , 2005 .
[175] R. Bartus,et al. The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.
[176] K. Davies,et al. Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.
[177] Colin W. Taylor,et al. Dynamic regulation of IP3 receptor clustering and activity by IP3 , 2009, Channels.
[178] P. Greengard,et al. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[179] M. Bortolozzi,et al. Presenilin 2 modulates endoplasmic reticulum (ER)–mitochondria interactions and Ca2+ cross-talk , 2011, Proceedings of the National Academy of Sciences.
[180] P. Koulen,et al. The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. , 2008, The international journal of biochemistry & cell biology.
[181] D. Westaway,et al. Amyloid-β-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice* , 2006, Journal of Biological Chemistry.
[182] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.
[183] K. Yano,et al. Dual sensitivity of sarcoplasmic/endoplasmic Ca2+-ATPase to cytosolic and endoplasmic reticulum Ca2+ as a mechanism of modulating cytosolic Ca2+ oscillations. , 2004, The Biochemical journal.
[184] Hajime Takano,et al. Suppression of InsP3 Receptor-Mediated Ca2+ Signaling Alleviates Mutant Presenilin-Linked Familial Alzheimer's Disease Pathogenesis , 2014, The Journal of Neuroscience.
[185] Tiina Manninen,et al. Effects of Transmitters and Amyloid-Beta Peptide on Calcium Signals in Rat Cortical Astrocytes: Fura-2AM Measurements and Stochastic Model Simulations , 2011, PloS one.
[186] S. Ferreira,et al. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease , 2014, Alzheimer's & Dementia.
[187] B. de Strooper,et al. Role of Presenilins in Neuronal Calcium Homeostasis , 2010, The Journal of Neuroscience.
[188] G. Hajnóczky,et al. MAM: more than just a housekeeper. , 2009, Trends in cell biology.
[189] Marc Cruts,et al. Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.
[190] P. Ghisdal,et al. Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death , 2004, Journal of neurochemistry.
[191] Jae Woong Lee,et al. PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[192] G. Wilcock,et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.
[193] I. Bezprozvanny. Presenilins and Calcium Signaling—Systems Biology to the Rescue , 2013, Science Signaling.
[194] F. LaFerla,et al. Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+ Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice , 2006, The Journal of Neuroscience.
[195] Y. Auberson,et al. Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N‐methyl‐D‐aspartate receptor in mature hippocampal cultures treated with amyloid‐β oligomers , 2012, Aging cell.
[196] Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies , 2010 .
[197] G. Dupont,et al. The progression towards Alzheimer's disease described as a bistable switch arising from the positive loop between amyloids and Ca(2+). , 2013, Journal of theoretical biology.
[198] E. Jazin,et al. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling , 2006, Neurobiology of Disease.